Bacterin International Holdings, Inc. (NYSEMKT:BONE), a leader in the development of revolutionary bone graft material and coatings for medical applications, on 19 march reported financial results for the fourth quarter and full year ended December 31, 2013. Bacterin International Holdings Inc. (NYSEMKT:BONE) shares after opening at $1.03 moved to $1.41 on last trade day and at the end of the day closed at $0.960. Company price to sales ratio in past twelve months was calculated as 1.51 and price to cash ratio as 14.57. Bacterin International Holdings Inc. (NYSEMKT:BONE) showed a positive weekly performance of 35.21%.
Cleveland BioLabs, Inc. (NASDAQ:CBLI) is a clinical-stage biotechnology company with a focus on oncology drug development. The Company’s lead drug candidate CBLB502 is developed for dual indications under the United States Food & Drug Administration’s (FDA’s) Animal Efficacy Rule, commonly referred to as the Animal Rule, as a radiation countermeasure, and under the FDA’s traditional drug approval pathway as an anti-cancer agent and an oncology supportive care therapy. Cleveland BioLabs, Inc. (NASDAQ:CBLI) shares advanced 12.15% in last trading session and ended the day on $0.808. CBLI return on equity ratio is recorded as 467.20% and its return on assets is -58.60%. Cleveland BioLabs, Inc. (NASDAQ:CBLI) yearly performance is -54.89%.
Palatin Technologies Inc. (NYSEMKT:PTN) was a big mover last session, with shares rising nearly 16% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. Palatin Technologies, Inc. (NYSEMKT:PTN) shares moved down -2.38% in last trading session and was closed at $1.23, while trading in range of $1.19 – $1.50. Palatin Technologies, Inc. (NYSEMKT:PTN) year to date (YTD) performance is 68.49%.
Flamel Technologies (NASDAQ:FLML) expects to release financial results for the fourth quarter and fiscal year 2013 on Tuesday, March 25, 2014, before the market open. Flamel Technologies S.A. (ADR) (NASDAQ:FLML) weekly performance is 38.03%. On last trading day company shares ended up $14.70. Flamel Technologies S.A. (ADR) (NASDAQ:FLML) distance from 50-day simple moving average (SMA50) is 40.98%. Analysts mean target price for the company is $11.00.
Leave a Reply